Amgen Inc. (AMGN) Free cash flow 2016–2025
Amgen Inc. (AMGN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$8.1BFY2025 · since FY2016: $9.6B → $8.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.1B | -22.1% |
| FY2024 | $10.4B | +41.2% |
| FY2023 | $7.4B | -16.2% |
| FY2022 | $8.8B | +4.8% |
| FY2021 | $8.4B | -15.2% |
| FY2020 | $9.9B | +15.9% |
| FY2019 | $8.5B | -19.2% |
| FY2018 | $10.6B | +0.4% |
| FY2017 | $10.5B | +9.3% |
| FY2016 | $9.6B | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice